Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy

Pediatric Hematology and Oncology

Volumn 16, Issue 2, 1999, Pages 101-108

  Stiakaki, Eftichia ^a   Savvas, Savvas ^a   Lydaki, Evaggelia ^a   Bolonaki, Irene ^a   Kouvidi, Efrossini ^a   Dimitriou, Helen ^a   Kambourakis, Alexandros ^a   Kalmanti, Maria ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Antiemetic agents; Chemotherapy; Ondansetron; Pediatric cancer; Tropisetron

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; ETOPOSIDE; GRANISETRON; IFOSFAMIDE; ONDANSETRON; SEROTONIN ANTAGONIST; TROPISETRON; UNCLASSIFIED DRUG; ZOFRON;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DRUG CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; NAUSEA; STATISTICAL ANALYSIS; VOMITING;

EID: 0032966347     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800199277425     Document Type: Article

References (21)

1. Coates A, Abraham S, Kaye SB. On the receiving end: patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol. 1983;19:203-208.
2. Sussman N. Reactions of patients to the diagnosís and treatment of cancer. Anti-Cancer Drugs. 1995;6: S4-S8.
3. Grunberg SM, Hesketh PJ. Control of chemotherapy-induced emesis. N Engl J Med. 1993;329:1790-1796.
4. Morrow GR, Hickok JT, Rosenthal SN. Progress in reducing nausea and emesis. Cancer. 1995;76:343-357.
5. Miyajima Y, Numata S, Katayama I, Horibe K. Prevention of chemotherapy-induced emesis with granisetron in children with malignant diseases. Am J Pediatr Hematol Oncol. 1994;16:236-241.
6. Jacobson SJ, Shore RW, Greenberg M, Spielberg SP. The efficacy and safety of granisetron in pediatric cancer patients who had failed standard antiemetic therapy during anticancer chemotherapy. Am J Pediatr Hematol Oncol. 1994;16:231-235.
7. Graft AW, Price L, Eden OB, et al. Granisetron as antiemetic therapy in children with cancer. Med Pediatr Oncol. 1995;25:28-32.
8. Hahlen K, Quintana E, Pinkerton R, Cedar E. A randomized comparison of intravenously administered granisetron versus chlorpromazine plus dexamethasone in the prevention of ifosfamide-induced emesis in children. J Pediatr. 1995;126:309-313.
9. Lemerle J, Amaral D, Southall DP, Upward J, Murdoch R. Efficacy and safely of granisetron in the prevention of chemotherapy-induced emesis in pediatric patients. Eur J Cancer. 1991;27:1081-1083.
10. Benoit Y, Hulstaert F, Vermylen C, et al. Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy. Med Pediatr Oncol. 1995;25:457-462.
11. Otten J, Hachini-Idrissi S, Balduck N, Maurus R. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies. Semin Oncol. 1994;21:S17-S19.
12. Cefalo G, Rottoli L, Armiraglio A, Pagan MG. Tropisetron (ICS 205-930) in pediatric oncology: first results in patients refractory to antiemetic metoclopramide-based treatments. Am J Pediatr Hematol Oncol. 1994;16:242-245.
13. Gershanovich M, Kolygin B, Pirgach N. Tropisetron in the control of nausea and vomiting induced by combined cancer chemotherapy in childern. Ann Oncol. 1993;4:S35-S37.
14. Cohen IJ, Zehari N, Buckwald I, et al. Oral ondansetron: an effective ampulatory complement to intravenous ondansetron in the control of chemotherapy-induced nausea and vomiting in children. Pediatr Hematol Oncol. 1995;12:67-72.
15. Lippens RJJ, Broeders GCJM. Ondansetron in radiation therapy of brain tumor in children. Pediatr Hematol Oncol. 1996;13:247-252.
16. Grala RJ. Antiemetic treatment for cancer chemotherapy: problems and progress. Support Care Cancer. 1994;2:275-276.
17. Mantovanni G, Maccio A, Bianchi A, et al. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized control trial. Cancer. 1996;77:941-948.
18. Marty M, Kleisbauer JP, Fournel P, et al. Is Navoban (tropisetron) as effective as Zofran (ondansetron) in cisplatin-induced emesis? Anti-Cancer Drugs. 1995;6:S15-S21.
19. Goldspiel BR, Curt GA. Issues in antiemetic therapy. Cancer. 1996;77:823-826.
20. Chevallier B, Marty M, Paillarse JM, and the Ondansetron Study Group. Methylprednisolone enhances the efficacy of ondansetron in acute and delayed cisplatin-induced emesis over at least three cycles. Br J Cancer. 1994;70:1171-1175.
21. Alvarez O, Freeman A, Bedros A, et al. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol. 1995;7:145-150.